Age-related decline in autonomic control of blood pressure: implications for the pharmacological management of hypertension in the elderly
- PMID: 12696992
- DOI: 10.2165/00002512-200320050-00001
Age-related decline in autonomic control of blood pressure: implications for the pharmacological management of hypertension in the elderly
Abstract
Autonomic control of blood pressure appears to decline with age giving rise to an increased risk of orthostatic hypotension and major hypotensive reactions to antihypertensive drugs. In the past few years, many workers have assessed autonomic function in the elderly and sometimes found controversial results. Baroreflex sensitivity, as measured by the steepness of the heart rate/mean pressure curve, decreases with age. However, this phenomenon does not correlate well with orthostatic impairment. Sympathetic dysfunction might be more responsible for syncopal symptoms in the elderly, a finding supported by the fact that elderly with orthostatic symptoms never collapse within a few seconds, but do so after 1 or more minutes of standing. However, the results of sympathetic function testing in the elderly indicate that sympathetic function in most elderly is not impaired and that sympathetic activity, as measured by circulating levels of catecholamines, is usually increased rather than decreased. In various populations with increased sympathetic activity, but not in the elderly, beta-adrenoceptor antagonists (beta-blockers) have been demonstrated to cause pressor effects, presumably due to alpha-adrenoceptor-mediated vasoconstriction unopposed by beta-receptor-mediated vasodilation. In the past year, large studies have been completed indicating that the same is true for the elderly, and that the depressor effect on pulse pressure upon standing in this category of patients can be offset and turned into a pressor effect by long-term beta-blocker treatment. This phenomenon could not be demonstrated with non-beta-blocker antihypertensive drugs, including ACE inhibitors, calcium channel antagonists, diuretics and angiotensin II receptor antagonists. In elderly patients beta-blockers may, therefore, be the most appropriate antihypertensive agents as they protect the elderly from orthostatic impairment.
Similar articles
-
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004. Drugs Aging. 2006. PMID: 16536636 Review.
-
Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect.Circulation. 2002 Apr 9;105(14):1669-71. doi: 10.1161/01.cir.0000012745.50229.ac. Circulation. 2002. PMID: 11940545 Clinical Trial.
-
The Role of Beta-Blockers in the Treatment of Hypertension.Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36. Adv Exp Med Biol. 2017. PMID: 27957711 Review.
-
Development and trends in the drug treatment of essential hypertension.J Hypertens Suppl. 1992 Dec;10(7):S1-12. J Hypertens Suppl. 1992. PMID: 1363322 Review.
-
Effect of antihypertensive agents on quality of life in the elderly.Drugs Aging. 2004;21(6):377-93. doi: 10.2165/00002512-200421060-00003. Drugs Aging. 2004. PMID: 15084140 Review.
Cited by
-
Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.Patient Relat Outcome Meas. 2011 Jul;2:27-39. doi: 10.2147/PROM.S8384. Epub 2011 Jan 25. Patient Relat Outcome Meas. 2011. PMID: 22915967 Free PMC article.
-
Attenuation of autonomic nervous system functions in hypertensive patients at rest and during orthostatic stimulation.J Clin Hypertens (Greenwich). 2008 Feb;10(2):97-104. doi: 10.1111/j.1751-7176.2008.07324.x. J Clin Hypertens (Greenwich). 2008. PMID: 18256574 Free PMC article.
-
The patient with supine hypertension and orthostatic hypotension: a clinical dilemma.Postgrad Med J. 2006 Apr;82(966):246-53. doi: 10.1136/pgmj.2005.037457. Postgrad Med J. 2006. PMID: 16597811 Free PMC article. Review.
-
The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004. Drugs Aging. 2006. PMID: 16536636 Review.
-
Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.Heart Fail Rev. 2008 Sep;13(3):367-75. doi: 10.1007/s10741-007-9060-z. Epub 2007 Nov 7. Heart Fail Rev. 2008. PMID: 17987382 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous